
Sanaria Announces Promising Early Safety Outcomes for Innovative PfSPZ-LARC2 Malaria Vaccine
In an inspiring leap forward in the global effort to conquer malaria, researchers at the Groupe de Recherche Action en Santé (GRAS) in Burkina Faso have announced a pivotal milestone in the clinical development of the Sanaria® PfSPZ-LARC2 Vaccine. This …